11. P14.06 Radiomics for the non-invasive determination of the BRAF mutational status in patients with melanoma brain metastases. (9th September 2021) Authors: Meissner, A; Gutsche, R; Galldiks, N; Kocher, M; Juenger, S T; Wendl, C; Mauch, C; Proescholdt, M; Grau, S; Lohmann, P Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. P14.17 Differentiation of treatment-related changes from tumor progression: A direct comparison between dynamic FET PET and ADC values obtained from DWI MRI. (6th September 2019) Authors: Werner, J; Stoffels, G; Lichtenstein, T; Borggrefe, J; Lohmann, P; Ceccon, G; Fink, G R; Langen, K; Kabbasch, C; Galldiks, N Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. P14.18 Prognostic value of serial dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with non-resectable malignant glioma undergoing chemoradiation. (6th September 2019) Authors: Rosen, J; Stoffels, G; Lohmann, P; Bauer, E K; Werner, J; Rapp, M; Felsberg, J; Fink, G R; Langen, K; Galldiks, N Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. P14.29 Prediction of overall survival in patients with malignant glioma using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET. (6th September 2019) Authors: Bauer, E K; Stoffels, G; Blau, T; Reifenberger, G; Werner, J M; Lohmann, P; Rapp, M; Fink, G R; Langen, K; Galldiks, N Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. P14.32 Spatial discrepancies between FET PET and conventional MRI in patients with newly diagnosed glioblastoma. (6th September 2019) Authors: Lohmann, P; Stavrinou, P; Lipke, K; Bauer, E K; Ceccon, G; Werner, J; Fink, G R; Shah, N J; Langen, K; Galldiks, N Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. P15.05.A Prediction of response to lomustine-based chemotherapy in glioma patients at relapse using MRI and FET PET. (5th September 2022) Authors: Wollring, M M; Werner, J; Bauer, E K; Tscherpel, C; Lohmann, P; Kabbasch, C; Goldbrunner, R; Fink, G R; Langen, K J; Galldiks, N Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. P17.19.B Incidence of treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma treated with cilengitide (EORTC 26071 - CENTRIC study): interim analysis. (5th September 2022) Authors: Flies, C M; Friedrich, M; Lohmann, P; van Garderen, K; Smits, M; Tonn, J C; Weller, M; Galldiks, N; Snijders, T J Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. PL01.6.A Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases. (5th September 2022) Authors: Gutsche, R; Lohmann, P; Hoevels, M; Ruess, D; Galldiks, N; Visser-Vandewalle, V; Treuer, H; Ruge, M I; Kocher, M Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗